The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Spotlight Series: HIV, the Gut and Digestive Issues
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

EU Says Trade Talks With India Will Not Hit Generic Drugs

May 7, 2010

The European Union's ambassador to India said on May 3 that ongoing free-trade negotiations are not intended to curb India's export of low-priced generic drugs.


India is the source of 80 percent of the AIDS drugs used by Doctors Without Borders (DWB) projects in developing nations. DWB has highlighted a leaked draft version of an EU-India deal covering generic drugs, saying that it would jeopardize India's status as the world's leading producer and exporter of generic drugs.

Any agreement reached would not be intended to limit India's ability "to produce and export life-saving [generic] medicines," said Daniele Smadja, the head of EU's delegation in New Delhi. The leaked draft is "not the text which will be in the agreement," as the text is still "subject to discussions and negotiations," she said.

The EU hopes to conclude the free-trade negotiations by late October, Smadja said. The EU launched talks for the agreement in 2007.

Back to other news for May 2010

Adapted from:
Agence France Presse

  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
See Also
Trade Negotiations Between EU, India Could Affect Access to Low-Cost Generics
EU-India Free-Trade Negotiations Could Limit Access to Affordable, Generic Drugs, Advocacy Group Says
More on Generic/Discount HIV Drug Access in the Developing World
Find out how a Walgreens specially trained pharmacist can help you